Published in Bioterrorism Week, April 4th, 2005
The goal of this program is to find a "universal" treatment for chemical, biological, radiological, and nuclear (CBRN) threats, such as Anthrax or dirty bombs.
The Proposal is under the auspices of the Ottawa and Suffield provencial branches of the Canadian Defense Ministry's R & D program, The CBRN Research and Technology Initiative.
"We believe Radilex to be one of the best universal protectant candidates...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Bioterrorism Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.